Gain Insights into the Strategies of Major Contenders - GSK

Gain Insights into the Strategies of Major Contenders - GSK and Merck, Along with Innovations from Sanofi and Themis

Global Adult Vaccines Market Global Adult Vaccines Market Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) -- The "Adult Vaccines Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global adult vaccines market is expected to grow from $18.20 billion in 2022 to $19.56 billion in 2023 at a compound annual growth rate (CAGR) of 7.49%.. The adult vaccines market is expected to reach $25.83 billion in 2027 at a CAGR of 7.20%. North America took the lead as the largest re

Related Keywords

United States , India , Russia , Ukraine , Austria , Dublin , Ireland , Switzerland , Austrian , America , Sanofi Pasteur , Sanofi Menquadfi , World Health Organization , Mitsubishi Tanabe Pharma Corporation , Serum Institute Of India , Daiichi Sankyo Company , Drug Administration , Segmentation By Technology , Emergent Biosolutions Inc , Merck Co , Protein Sciences Corporation , Immunobiology Ltd , Johnson , Dynavax Technologies Corporation , Novavax Inc , Pfizer Inc , Global Adult Vaccines , Vaccines Global Market Report , Topics Covered , Vaccines Market , Vaccines Market Trends And , Adult Vaccines , Russia War Impact On Adult Vaccines , High Inflation On Adult Vaccines , Vaccines Market Size And , Adult Vaccines Historic Market , Adult Vaccines Forecast Market , Adult Vaccines Market , Segmentation By Vaccine Type , Segmentation By Application , Segmentation By End Users , Vaccines Market Regional And Country , Split By Region , Split By Country , Vaccines , Global Market , Live Attenuated Vaccines , Immune Response ,

© 2025 Vimarsana